KR20190084287A - 연골 손상 및 관절염 치료 방법 및 조성물 - Google Patents

연골 손상 및 관절염 치료 방법 및 조성물 Download PDF

Info

Publication number
KR20190084287A
KR20190084287A KR1020197016715A KR20197016715A KR20190084287A KR 20190084287 A KR20190084287 A KR 20190084287A KR 1020197016715 A KR1020197016715 A KR 1020197016715A KR 20197016715 A KR20197016715 A KR 20197016715A KR 20190084287 A KR20190084287 A KR 20190084287A
Authority
KR
South Korea
Prior art keywords
asn
gly
ser
glu
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020197016715A
Other languages
English (en)
Korean (ko)
Inventor
크리스틴 존슨
요르크 골트한
첼레스테 슈코티
이고어 포스티아어
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Priority to KR1020247009753A priority Critical patent/KR20240045351A/ko
Publication of KR20190084287A publication Critical patent/KR20190084287A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020197016715A 2016-11-14 2017-11-13 연골 손상 및 관절염 치료 방법 및 조성물 Ceased KR20190084287A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020247009753A KR20240045351A (ko) 2016-11-14 2017-11-13 연골 손상 및 관절염 치료 방법 및 조성물

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662421534P 2016-11-14 2016-11-14
US62/421,534 2016-11-14
US201762560301P 2017-09-19 2017-09-19
US62/560,301 2017-09-19
PCT/IB2017/057081 WO2018087727A1 (en) 2016-11-14 2017-11-13 Methods and compositions for treatment of cartilage damage and arthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020247009753A Division KR20240045351A (ko) 2016-11-14 2017-11-13 연골 손상 및 관절염 치료 방법 및 조성물

Publications (1)

Publication Number Publication Date
KR20190084287A true KR20190084287A (ko) 2019-07-16

Family

ID=60629753

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020197016715A Ceased KR20190084287A (ko) 2016-11-14 2017-11-13 연골 손상 및 관절염 치료 방법 및 조성물
KR1020247009753A Pending KR20240045351A (ko) 2016-11-14 2017-11-13 연골 손상 및 관절염 치료 방법 및 조성물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020247009753A Pending KR20240045351A (ko) 2016-11-14 2017-11-13 연골 손상 및 관절염 치료 방법 및 조성물

Country Status (10)

Country Link
US (3) US11351223B2 (https=)
EP (1) EP3538127A1 (https=)
JP (2) JP2019535707A (https=)
KR (2) KR20190084287A (https=)
CN (2) CN109963579A (https=)
AU (2) AU2017357785A1 (https=)
CA (1) CA3043667A1 (https=)
IL (1) IL266361B2 (https=)
MX (2) MX2019005621A (https=)
WO (1) WO2018087727A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024519893A (ja) 2021-05-24 2024-05-21 ノバルティス アーゲー 変形性関節症の治療方法
TW202306970A (zh) 2021-05-24 2023-02-16 瑞士商諾華公司 用於治療骨關節炎之方法
CN118251594A (zh) * 2021-11-10 2024-06-25 诺华股份有限公司 用于确定angptl多肽的生物活性的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083970B2 (en) 2001-04-19 2006-08-01 The Scripps Research Institute Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
MXPA05003978A (es) 2002-10-16 2005-06-22 Scripps Research Inst Sintesis de glicoproteinas.
ES2324608T3 (es) 2002-10-16 2009-08-11 The Scripps Research Institute Incorporacion especifica de sitio de cetoaminoacidos en proteinas.
WO2004094593A2 (en) 2003-04-17 2004-11-04 The Scripps Research Institute Expanding the eukaryotic genetic code
US20060160175A1 (en) 2003-07-07 2006-07-20 The Scripps Research Institute Compositions of orthogonal leucyl-trna and aminoacyl-trna synthetase pairs and uses thereof
WO2005007624A2 (en) 2003-07-07 2005-01-27 The Scripps Research Institute Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
WO2005019415A2 (en) 2003-07-07 2005-03-03 The Scripps Research Institute Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
CA2580840A1 (en) 2004-09-21 2006-03-30 The Scripps Research Institute In vivo incorporation of alkynyl amino acids into proteins in eubacteria
EP1807515A4 (en) 2004-10-27 2008-06-18 Scripps Research Inst Orthogonal translation components for the in vivo incorporation of unnatural amino acids
US7960141B2 (en) 2006-03-09 2011-06-14 The Scripps Research Institute Systems for the expression of orthogonal translation components in eubacterial host cells
EP2118150B1 (en) 2007-02-14 2015-09-23 Biocompatibles UK Limited Derivatisation of biological molecules
US8858940B2 (en) * 2008-12-10 2014-10-14 Ablynx N.V. Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
AU2010273570B2 (en) * 2009-07-14 2014-07-03 Novartis Ag Mesenchymal stem cell differentiation
UY32979A (es) * 2009-10-28 2011-02-28 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
AU2013204754C1 (en) * 2012-05-16 2018-10-11 Takeda Pharmaceutical Company Limited Nucleophilic Catalysts for Oxime Linkage
JO3564B1 (ar) * 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
US9301971B2 (en) * 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
ES2900815T3 (es) * 2013-03-15 2022-03-18 Scripps Research Inst Compuestos y métodos para inducir la condrogénesis
EP3143026B1 (en) * 2014-05-13 2024-07-10 Novartis AG Compounds and compositions for inducing chondrogenesis

Also Published As

Publication number Publication date
AU2020281098B2 (en) 2024-05-02
IL266361B1 (en) 2023-10-01
EP3538127A1 (en) 2019-09-18
JP2023039962A (ja) 2023-03-22
US20250302915A1 (en) 2025-10-02
CN109963579A (zh) 2019-07-02
WO2018087727A1 (en) 2018-05-17
IL266361A (en) 2019-06-30
MX2022011897A (es) 2022-10-18
US11351223B2 (en) 2022-06-07
MX2019005621A (es) 2019-08-12
US20220331398A1 (en) 2022-10-20
CN117860868A (zh) 2024-04-12
CA3043667A1 (en) 2018-05-17
AU2020281098A1 (en) 2021-01-14
RU2019117884A (ru) 2020-12-14
IL266361B2 (en) 2024-02-01
JP2019535707A (ja) 2019-12-12
RU2019117884A3 (https=) 2021-02-05
KR20240045351A (ko) 2024-04-05
AU2017357785A2 (en) 2019-05-02
AU2017357785A1 (en) 2019-04-11
US20190269754A1 (en) 2019-09-05

Similar Documents

Publication Publication Date Title
US20220184182A1 (en) Peptides and compositions for treatment of joint damage
US20220402987A1 (en) Peptides and compositions for treatment of joint damage
US20250302915A1 (en) Methods and compositions for treatment of cartilage damage and arthritis
RU2777504C2 (ru) Способы и композиции для лечения повреждения хряща и артрита
HK1260928A1 (en) Peptides and compositions for treatment of joint damage
HK1214754B (en) Peptides and compositions for treatment of joint damage

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190611

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201104

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220816

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20230425

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220816

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20230425

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20221214

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20201104

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20231024

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20230918

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20230425

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20221214

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20220816

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20201104

X601 Decision of rejection after re-examination